|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2003-4-28
|
|
pubmed:abstractText |
Controversy exists about the optimal immunosuppressive regimen in simultaneous kidney-pancreas transplant (SKPT) recipients. This study determined the safety and efficacy of two dosing regimens of daclizumab compared with no antibody induction in SKPT recipients receiving tacrolimus, mycophenolate mofetil, and steroids.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
27
|
|
pubmed:volume |
75
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1260-6
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12717213-Adult,
pubmed-meshheading:12717213-Antibodies, Monoclonal,
pubmed-meshheading:12717213-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:12717213-Drug Administration Schedule,
pubmed-meshheading:12717213-Female,
pubmed-meshheading:12717213-Graft Rejection,
pubmed-meshheading:12717213-Graft Survival,
pubmed-meshheading:12717213-Humans,
pubmed-meshheading:12717213-Immunoglobulin G,
pubmed-meshheading:12717213-Immunosuppressive Agents,
pubmed-meshheading:12717213-Incidence,
pubmed-meshheading:12717213-Kidney,
pubmed-meshheading:12717213-Kidney Transplantation,
pubmed-meshheading:12717213-Male,
pubmed-meshheading:12717213-Middle Aged,
pubmed-meshheading:12717213-Pancreas,
pubmed-meshheading:12717213-Pancreas Transplantation,
pubmed-meshheading:12717213-Survival Analysis
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study.
|
|
pubmed:affiliation |
Wake Forest University Baptist Medical Center, Department of General Surgery, Winston-Salem, NC 27157-1095, USA. rstratta@wfubmc.edu.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
